Topic: BT&D² Bidirectional AI Drug Intelligence Engine: A Multimodal Evidence-Fusion Platform for End-to-End Pharmaceutical R&D
Abstract: The BT&D² Bidirectional AI Drug Intelligence Engine is a multimodal, evidence-driven platform designed to accelerate drug discovery by integrating four core biomedical databases covering disease targets, conventional and traditional medicines, drug-modifying enzymes, and evidence-based medicine. Through its bidirectional “Diseases-Find-Drugs” and “Drugs-Find-Diseases” workflows, the platform combines knowledge graphs, GraphRAG, generative molecular design, and multiparameter evaluation to prioritize targets, identify promising compounds, and optimize drug candidates. By linking AI predictions with experimental validation and iterative feedback, BT&D² supports transparent, evidence-based decision-making throughout drug development.
Five applications demonstrate its translational potential: AI-optimized compounds with potent anticancer and anti-metastatic activities in triple-negative breast cancer; herbal formulations improving bone formation and density in osteoporosis models; a medicinal-fungus-derived compound exhibiting dual antiviral activity against SARS-CoV-2 proteases; botanical formulations promoting scar healing; and standardized botanical extracts targeting skin pigmentation. Together, these studies illustrate how BT&D² bridges computational discovery and preclinical validation across diverse therapeutic areas, providing a practical framework for target validation, lead optimization, experimental design, and collaborative drug development.
(Full abstract: https://shorturl.at/fyoBo)
Time: 2026.11.12 (Thursday) 10:30 am
Venue: Lecture Room C212, Building C, National Biotechnology Research Park
Speaker: Dr. Hsien-Tai Chiu
Associate Professor, Department of Chemistry, College of Science,
Adjunct Associate Professor, Institute of Biochemistry and Molecular Biology, College of Medicine,
Director, Taiwan BT&D2 Team,
Chairman & Founder, Asia-Pacific BT&D2 Alliance (APBA),
National Cheng Kung University
Host: Dr. Chien-Chang Chen
Director, Biomedical Translation Research Center
Organizer: Biomedical Translation Research Center, Academia Sinica
Registration: https://forms.gle/w1kB5J9CSypfRNpE7
